Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

3Shape Files Lawsuit Against Align Technology for Alleged Abuse of Monopoly Power

Copenhagen, August 28, 2018 – 3Shape, a leading innovator and manufacturer of 3D digital scanners and CAD/CAM software solutions for dental practices and labs, today filed a lawsuit against Align Technology for allegedly acting illegally to block competition in the marketplace for scanners for orthodontic treatment, including clear aligners. The lawsuit, styled 3Shape TRIOS A/S v Align Technology, Inc., was filed in the U.S. District Court for the District of Delaware. “Align is illegally holding on to their monopoly of clear aligners after expiry of many of their patents, by

CEO letter Aug 2018

Dear Shareholders,   After the H1 report that was released on Friday, 24th of August 2018 many shareholders have contacted us with different questions. With this CEO letter I will try to answer some of those questions. The translation between the English and Swedish reports resulted in some ambiguity. We at Goldblue AB apologize for that and will do our best to avoid this type of situation in the future. In 2017 we had a presence in two markets (the Chinese and the Japanese speaking markets). In 2018 we have as a strategy to enter into other emerging markets. The implementation of

VEGAS Pro 16 released – More power, more speed, more creative freedom

A high-performance video engine, intelligent workflow enhancements, and powerful, state-of-the-art editing features solidify VEGAS Pro as a cutting-edge tool for the professional market.Madison, WI – August 27, 2018 – VEGAS Creative Software delivers next-generation video editing with the release of VEGAS Pro 16. With a high-performance video engine, intelligent workflow enhancements, and long-awaited, state-of-the-art editing features, the fastest video editor on the market is now packed with more power, speed, and innovation.  VEGAS Pro 16 delivers the groundbreaking improvements to

ABB demonstrates digital future of power grid design and planning

Innovative application on display at CIGRE 2018 uses Virtual Reality based technology to enable customers to “walk through” projectsABB is taking the digitalization of power grids design technology to the next level with its innovative new 3D/VR design and planning tool, being demonstrated live at CIGRE 2018, in Paris from August 27-31. The ABB Ability™-enabled tool represents an industry-wide step change in design and planning technology and will optimize the process of building power infrastructure like substations, making them safer, more efficient and cost-effective. Users will be

Crecia-Kasuga started up a Valmet Advantage Tissue machine in Japan

Valmet Oyj's trade press release on August 28, 2018, at 11:00 a.m. EET Crecia-Kasuga Co., Ltd has successfully started up a new tissue line, jointly delivered by Valmet and Kawanoe Zoki Co., Ltd., at the company's new production facility in Fuji, Japan. The inauguration ceremony was held during summer and the line is now in full operation producing tissue products for the Japanese consumer market. The project has been very successful and the cooperation between Valmet, Kawanoe Zoki and Crecia-Kasuga has been smooth and efficient. "We at Valmet appreciate the fruitful cooperation

TOMRA: Registration for Capital Markets Day 2018

TOMRA SYSTEMS ASA has the pleasure of inviting shareholders, investors, analysts, lenders and media to the TOMRA 2018 Capital Markets Day (CMD). The CMD will be held at TOMRA headquarters in Asker, Norway on the 21st of September 2018. To secure your attendance and to receive information about the CMD, please follow the link to our website for registration to attend the event in Asker: https://www.tomra.com/en/investor-relations/capital-markets-day Participation will also be possible via a live webcast. All presentations will be made available for download on our website on the day

Lorelei Lingard is awarded the Karolinska Institutet Prize for Research in Medical Education

Professor Lorelei Lingard is awarded the 2018 Karolinska Institutet Prize for Research in Medical Education. Her research has contributed significantly to our understanding of how healthcare professionals interact and communicate with each other, which has led to new clinical practices and increased patient safety.Professor Lingard, Professor in the Department of Medicine at the Schulich School of Medicine & Dentistry and cross-appointed in the Faculty of Education at Western University in Canada, will receive the award and a prize amount of €50,000 at a ceremony in Stockholm, Sweden, on 11

MPC Container Ships ASA reports H1 and Q2 2018 results

MPC Container Ships ASA (the "Company") will be releasing its half-year and second quarter 2018 report prior to market opening on Friday 31 August 2018.The Company will host a webcast for the presentation of the report commencing on Friday 31 August 2018 at 15:00 hours CEST, followed by a Q&A session. Dial-in information for the earnings call will be made available with the release of the half-year and second quarter 2018 report. Oslo, 28 August 2018 - MPC Container Ships ASA reports H1 and Q2 2018 results MPC Container Ships ASA (the "Company") will be releasing its half-year and

YIT has signed an agreement with the City of Kalajoki on the construction of the Merenoja comprehensive school

YIT Corporation Investor News 28 August, 2018 at 10:15 a.m.YIT has signed an agreement with the City of Kalajoki on the construction of the Merenoja comprehensive school. The school will be the first comprehensive school in Finland to carry the Nordic Swan Ecolabel. The project will be implemented as a turnkey contract consisting of demolition work on the old buildings and the construction of a new school building and sports facilities. Construction will begin in autumn 2018 and the interior parts will be completed in July 2020. Demolition and exterior work is scheduled to be completed by

OmniCar adjusts its strategy: Stronger focus on lucrative car dealer segment

While OmniCar’s long-term goal remains the same, the company has decided to turn its strategic focus to authorised car dealers, car importers and large workshop chains. Additionally, OmniCar introduces its Service Agreement Management (SAM) solution in three different packages and price levels, ranging from a monthly license fee from SEK 395 to SEK 3,295 and an onboarding fee of up to SEK 13,000. The 5% commission fee to OmniCar will discontinue. OmniCar’s Service Agreement Management solution has been on the market since the end of 2017 and the company has now gained the necessary

Helen selects Tieto Smart Utility for digitalizing its business and increase customer experience

Finnish energy company Helen has selected the Tieto Smart Utility cloud solution to support its retail and distribution business. The new services improve competitiveness and operational efficiency by digitalizing the company’s key processes and increasing the customer experience. This change also enables an easy connection to the data hub, the upcoming centralised data exchange solution for energy companies.Helen is one of the leading energy companies in Finland with more than 400,000 customer sites. Tieto Smart Utility optimises Helen’s key customer processes, such as multi-channel

Upcoming events and conferences for NXTCL

Stem cell company NextCell Pharma AB ("NXTCL") announces today, that CEO Mathias Svahn has been invited to speak at the annual BiotechBuilders event held today, 28th of September 2018. Mathias Svahn will also give a presentation at the Nordic Life Science Days, which will be held 10th-12th of September 2018.The BiotechBuilders event which is held today, 28th of September 2018, has invited CEO Mathias Svahn to speak about NXTCL and how the company has developed over time. The title of his presentation is: “Turning opportunity into productivity, starting a stem cell clinical trial in record

NeuroVive’s NVP015 program will be accelerated through award of major research grant to Children’s Hospital of Philadelphia

Lund, Sweden, 28 August, 2018, NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that scientists at the company’s research partner the Children’s Hospital of Philadelphia (CHOP) have received a three-year grant (W81XWH-17-PRMRP-TTDA), in total of $4,090,281 USD, from the U.S. Department of Defense, Office of the Congressionally Directed Medical Research Programs (CDMRP) for studies focused on NeuroVive’s NVP015 program for genetic mitochondrial diseases.The extensive program evaluating preclinical efficacy and exploring viable future clinical endpoints for

Translation to English - Summary of the Enersize Interim Report (2018 H1)

For any discrepancies compared to the original Swedish text we refer to the Swedish wordings. This is a translation of previously released information. The original report in Swedish can be found at:  www.enersize.com/rapporter/  Please note that the financial information, images and charts from the Swedish version is not included in this text. please see the attached downloadable original H1 report pdf for images & charts.The "Company" or "Enersize" refers to Enersize Oyj with the Finnish organization number 2317518-8. "First North" refers to Nasdaq Stockholm First North. Amount in

Half-Yearly Report January – June 2018

April–June in brief · Net sales rose by about 48 percent to SEK 8,578k (5,812k). · Operating result before depreciation and amortization (EBITDA)* totaled SEK -596k (-1,624). · Comprehensive income for the period improved by SEK 352k to a loss of SEK 1,793 (loss: 2,145k). · Comprehensive income per share, basic and diluted, improved by SEK 0.01 to SEK -0.03 (-0.04). · Genovis signed distribution agreement for the South Korean market · Strengthened marketing organization in the US and Kevin Cook hired as Senior Application & Market Area Manager for the subsidiary

AVTECH Sweden AB (publ) INTERIM REPORT January - June 2018

· AVTECH Group's turnover for the second quarter of 2018 amounted to MSEK 3.3 (2.4). · Operating profit before depreciation for the second quarter of 2018 was MSEK 0.2 (-1.1) and for the six-month period MSEK 0.4 (0.5). Net profit for the second quarter of 2018 amounted to MSEK -0.9 (-1.1) and for the six-month period -1.8 (-2.4) or SEK -0.03 (-0.03) per share. · Cash flow from operating activities for the second quarter of 2018 amounted to MSEK -0.2 (-0.1) and for the six-month period -0.5 (-2.8). The Group's cash and cash equivalents at the end of the period amounted to MSEK 17.4 (

Susanne Lithander leaves Serneke's board

Susanne Lithander resigns from her assignment as a board member of Serneke Group AB. The reason is that she has accepted a new position as CFO in a competing company in the same industry."We understand and respect Susanne's decision and thank her for her efforts in the board. We wish her the best of luck in the future, says Kent Sander, Chairman of Serneke Group AB. Work on supplementing Serneke's board has begun. For additional information, please contact: Anders Düring, CFO Serneke Group ABTel: +46 70 888 7733anders.during@serneke.se Johan Live, Press Officer, Serneke

Follicum AB announces that all patients have completed the treatment with FOL-005 in the Phase IIa study against hair loss.

Top-line data will be presented in the autumn. Follicum AB ("Follicum" or "The Company") today announces that all patients in the ongoing Phase IIa study with FOL-005 for hair loss have completed the treatment and finalized clinic visits. The Phase IIa study examines the safety and therapeutic effect of various doses of drug candidate FOL-005, administered as injections into the scalp.Follicum’s Phase IIa study is being conducted at the Clinical Research Center for Hair and Skin Science ("CRC") in Berlin and at Bioskin, Hamburg, Germany. The study is blinded, and results will not be

Faroe Petroleum plc Announces DNO Withdraws Faroe General Meeting Requisition

28 August 2018     Faroe Petroleum plc   ("Faroe", "Faroe Petroleum", the "Company")  DNO Withdraws Faroe General Meeting Requisition     The Board of Faroe Petroleum plc ("Faroe," "Company," "Board"), the independent oil and gas Company focusing principally on exploration, appraisal and production opportunities in Norway and the UK, notes that DNO ASA ("DNO") has withdrawn its notice requisitioning a General Meeting to appoint its own nominated directors to the Board.   The Board is pleased that DNO has withdrawn the requisition which would have been costly and time

Beactica closes financing round to accelerate its pipeline of novel cancer therapeutics

Uppsala, Sweden – 28 August 2018Beactica , the Swedish drug discovery company, today announced the completion of its latest financing round, providing significant funds that will be used to advance the Company’s internal pipeline of discovery-stage oncology programmes. The financing round was Beactica’s most successful to date, being almost 60% oversubscribed. Over one third of the investors were new to Beactica, raising the majority of the funds. The remainder was provided by several existing shareholders, including ALMI Invest and UNIONEN. The funds raised will

Ahlsell acquires Norwegian distributor within tools and PPE

Ahlsell AS has signed an agreement to acquire Bygg & Industrisalg AS (Bygg & Industrisalg), a Norwegian distributor of tools and PPE (Personal Protective Equipment). The company is based in Sandnes, has 13 employees and annual sales of approximately MNOK 40. Since 2009, Bygg & Industrisalg offers a wide range of tools and PPE to professional customers in the region around Stavanger, in South West Norway. The existing customer base is wide and covers customer within state and municipalities, construction, transport and oil industry. "Bygg & Industrisalg has a highly competent and

InDex Pharmaceuticals Holding AB (publ) interim report January – June 2018

Updated timeline for the top line results from the CONDUCT studyPeriod April – June 2018   · Revenues amounted to SEK 0.0 (0.0) million · Operating result amounted to SEK –26.0 (–15.4) million · Result after tax amounted to SEK –26.0 (–15.2) million, corresponding to SEK –0.42 per share (–0.24) before and after dilution · Cash flow from operating activities amounted to SEK –19.7 (–18.4) million Period January – June 2018 · Revenues amounted to SEK 0.1 (0.1) million · Operating result amounted to SEK –44.8 (–37.5) million · Result after tax amounted to SEK –44.7 (–

Extraordinary General Meeting in Ripasso Energy AB (publ)

The shareholders of Ripasso Energy AB are hereby invited to attend the Extraordinary General Meeting (“EGM”) to be held at 2 p.m. CET on Thursday 13 September 2018 at Mannheimer Swartling Advokatbyrå Offices, at the address Norrlandsgatan 21, Stockholm. Registration will commence at 1.30 p.m. CET.A. RIGHT TO PARTICIPATE IN THE EXTRAORDINARY GENERAL MEETING Shareholders who wish to participate in the EGM must: firstly, be registered in the share register maintained by Euroclear Sweden AB no later than Friday 7 September 2018, and secondly, notify the company of their intention to

Faroe Petroleum plc Announces Agar/Plantain Exploration and Appraisal Well Commences

28 August 2018  Faroe Petroleum plc   ("Faroe", "Faroe Petroleum", the "Company")    Agar/Plantain Exploration and Appraisal Well Commences     Faroe Petroleum, the independent oil and gas company focusing principally on exploration, appraisal and production opportunities in Norway and the UK, notes the announcement made today by Azinor Catalyst Limited ("Catalyst"), the operator of the Agar Plantain exploration and appraisal well on the UK Continental Shelf ("UKCS").  Catalyst confirmed that the Plantain exploration well spud at approximately 6:00pm on 24 August 2018

There are no items matching the current filter
There are no more items matching the current filter
Back to top